EVIDENCE OF TOLERANCE DEVELOPMENT TO THE HYPERPHAGIC BUT NOT ANXIOLYTIC-LIKE ACTIONS OF SB-200646A, A 5-HT2C/5-HT2B RECEPTOR ANTAGONIST, AFTER CHRONIC TREATMENT

被引：0
|
作者：
KENNETT, GA [1 ]
GREWAL, S [1 ]
BLACKBURN, TP [1 ]
机构：
[1] SMITHKLINE BEECHAM PHARMACEUT,HARLOW CM19 5AW,ESSEX,ENGLAND
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1995年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P370 / P370
页数：1
相关论文
共 50 条
  • [41] Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment
    Richard M. Kostrzewa
    Nuo-Yu Huang
    John P. Kostrzewa
    Przemyslaw Nowak
    Ryszard Brus
    Neurotoxicity Research, 2007, 11 : 41 - 50
  • [42] Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice
    Dhonnchadha, BAN
    Hascoët, M
    Jolliet, P
    Bourin, M
    BEHAVIOURAL BRAIN RESEARCH, 2003, 147 (1-2) : 175 - 184
  • [43] Modeling tardive dyskinesia:: Predictive 5-HT2C receptor antagonist treatment
    Kostrzewa, Richard M.
    Huang, Nuo-Yu
    Kostrzewa, John P.
    Nowak, Przemyslaw
    Brus, Ryszard
    NEUROTOXICITY RESEARCH, 2007, 11 (01) : 41 - 50
  • [44] Effects of SB 206553, a 5-HT2C/2B receptor antagonist, in a marmoset conflict model of anxiety
    Bright, F
    Cilia, J
    Piper, D
    Blackburn, T
    Kennett, G
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P153 - P153
  • [45] The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo
    Beattie, DT
    Smith, JAM
    Marquess, D
    Vickery, RG
    Armstrong, SR
    Pulido-Rios, T
    McCullough, JL
    Sandlund, C
    Richardson, C
    Mai, N
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (05) : 549 - 560
  • [46] 5-HT2C receptor modulation and the treatment of obesity
    Bickerdike, MJ
    Vickers, SP
    Dourish, CT
    DIABETES OBESITY & METABOLISM, 1999, 1 (04): : 207 - 214
  • [47] Rational Drug Design Leading to the Identification of a Potent 5-HT2C Agonist Lacking 5-HT2B Activity
    Chen, Gang
    Cho, Sung Jin
    Huang, Xi-Ping
    Jensen, Niels H.
    Svennebring, Andreas
    Sassano, Maria F.
    Roth, Bryan L.
    Kozikowski, Alan P.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (12): : 929 - 932
  • [48] A 5-HT2C receptor agonist for the treatment of obesity?
    Van Baak, M
    Lentjes, M
    Mujakovic, S
    Slaap, B
    Saris, W
    OBESITY RESEARCH, 2003, 11 : A110 - A111
  • [49] 5-HT2A BUT NOT 5-HT2C OR 5-HT2B RECEPTORS MAY MODULATE BLINKING INDUCED BY THE TRH ANALOG MK771
    MCCREARY, AC
    HANDLEY, SL
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P219 - P219
  • [50] Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine
    McCreary, AC
    Cunningham, KA
    NEUROPSYCHOPHARMACOLOGY, 1999, 20 (06) : 556 - 564
12345